Authors: Iyengar, RV Pawlik, CA Krull, EJ Phelps, DA Burger, RA Harris, LC Potter, PM Danks, MK

Citation: Rv. Iyengar et al., Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression, CANCER RES, 61(7), 2001, pp. 3045-3052

Authors: Meck, MM Wierdl, M Wagner, LM Burger, RA Guichard, SM Krull, EJ Harris, LC Potter, PM Danks, MK

Citation: Mm. Meck et al., A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11, CANCER RES, 61(13), 2001, pp. 5083-5089

Authors: Pawlik, CA Iyengar, RV Krull, EJ Mason, SE Khanna, R Harris, LC Potter, PM Danks, MK Guichard, SM

Citation: Ca. Pawlik et al., Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells toCPT-11, MOL THER, 1(5), 2000, pp. 457-463

Authors: Danks, MK Morton, CL Krull, EJ Cheshire, PJ Richmond, LB Naeve, CW Pawlik, CA Houghton, PJ Potter, PM

Citation: Mk. Danks et al., Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy, CLIN CANC R, 5(4), 1999, pp. 917-924

Authors: Guichard, SM Morton, CL Krull, EJ Stewart, CF Danks, MK Potter, PM

Citation: Sm. Guichard et al., Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase, CLIN CANC R, 4(12), 1998, pp. 3089-3094